Validation of Multi-contrast, High-resolution Cardiac Magnetic Resonance Imaging
NCT05877755
Summary
Cardiovascular disease (CVD) causes at least 1.8 million European deaths annually, exceeding fatalities from cancer, chronic respiratory disease, and diabetes. Consequently, the fight against CVD has become the main priority of the World Health Organization. In the pursuit of understanding and treating CVD, cardiac magnetic resonance imaging (CMR) has remained the only modality capable of providing a comprehensive assessment of the heart's function and structure without harmful radiation. Unfortunately, current CMR systems remain too slow, too complex, require highly trained specialists and, as such, have presented a barrier to a wider adoption of CMR. The aim of CARDIO-IRM is to unleash the full potential of CMR to transform patient trajectories by introducing a fast, one-click, fully automated, and comprehensive imaging pipeline applicable to diagnosis, prognosis, and therapy selection in cardiology.
Eligibility
Inclusion Criteria: * Adult patient (over 18 years of age) requiring an MRI scan as part of their care. * Male or female. * Affiliated or beneficiary of a social security scheme * Having given his/her oral no objection after having read the information note Exclusion Criteria: * Patient unable to give oral consent (guardianship, non-French speaker, etc.) * Patient deprived of liberty * Patient who does not meet the specific eligibility criteria for an MRI examination: pregnant women, known pathology that may interfere with acquisition (e.g. Parkinson's disease), absolute or relative contraindication to an MRI examination * Patient participating in a therapeutic interventional trial or in a period of relative exclusion in relation to another protocol
Conditions2
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT05877755